1Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT).Bone Marrow Transplant, 1997,19: 643-645.
2Tyndall A, Gratwohl A. Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease. Curr Opin Hematol,1997,4:390-394.
3Burt RK. BMT for severe autoimmune diseases: an idea whose time has come. Oncology (Huntingt),1997,11:1001-1017.
4Hahn BH. The potential role of autologous stem cell transplantation in patients with systemic lupus erythematosus. J Rheumatol Suppl,1997,48:89-93.
5Van Laar JM,Tyndall A. Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review. Cancer Control,2003,10:57-65.
6Burt RK, Traynor AE, Craig R, et al. The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant,2003,31:521-524.
8Oksenberg JR, Hauser SL. Emerging concepts of pathogenesis:relationship to multiple sclerosis therapies. In: Rudick RA,Goodkin DE (eds). Multiple sclerosis therapeutics. MartinDunitz: London, 1999.215-242.
9Burt RK, Traynor AE, Cohen B,et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant,1998,21: 537-541.
10Fassas A, Passweg JR, Anagnostopoulos A, et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol, 2002, 249:1088-1097.
2Hoogerbrugge PM, Brouwer OF, Bordigoni P, et al. Allogeneic bone marrow transplantation for lysosomal storage diseases[J].Lancet, 1995,345(8962):1398 - 1402.
3Kennedy DW, Abkowitz JL. Kinetics of central nervous system microglial and macrophage engraftment:analysis using a transgenic bone marrow transplantation model[J]. Blood, 1997,90(3)986- 993.
4Norflus F, Tifft CJ, McDonald MP. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice[J]. Clin Invest, 1998,101(9):1881-1888.
5Peters C, Balthazor M, Shapiro EG, et al. Outcome of unrelated donor bone marrow transplantation in forty children with Hurler syndrome[J]. Blood, 1996,87(11):4894 - 4902.
6Peters C, Shapiro EG, Amderson J, et al. Hurler Syndrome Ⅱ.Outcome of HLA-genotypically identical sibling and HLAhaploidentical related donor bone marrow transplantation in fiftyfour children[J]. Blood, 1998,91(7):2601 - 2608.
7Lee V, Li CK, Shing MM, et al. Umbilical cord blood transplantation for Maroteaux-Lamy syndrome(mucopolysaccharidosis type Ⅵ)[J]. Bone Marrow Transplant, 2000,26(4):455-458.
8Kapelushnik J, Mandel H, Varadi G, et al. Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome[J]. J Pediatr Hematol Oncol,2000,22(5):433 - 436.
9Peters C, Shapiro EG, Krivit W, et al. Hurler syndrome: past,present, and future[J]. J Pediatr, 1998,133(1):7-9.
10Vellodi A, Young E, Cooper A, et al. Long-term follow-up following bone marrow transplantation for Hunter disease[J]. J Inherit Metab Dis, 1999,22(5):638- 648.
